Analysis of IVD reagent industry

Release time:


With the increasing demand for clinical diagnosis and the continuous improvement of R&D technology, in vitro diagnosis (IVD) industry has become one of the fastest growing and most active sub-industries in China's pharmaceutical industry. Although the in vitro diagnostic industry in China is still in its early stage of development, its development has been supported by the national industrial policy. During the Eleventh Five-Year Plan period, the National 863 Program supported the key projects of biomedical reagents for the first time. Since 2005, the relevant government departments have issued a number of policies, including the development of in vitro diagnostic reagents, diagnostic instruments, diagnostic enzymes and other industries as key development projects, and in vitro diagnosis as one of them. Strategic emerging industries.
In Vitro Diagnosis, abbreviated as IVD, is a broad concept. It refers to the products and services for obtaining clinical diagnostic information from human samples (blood, body fluids, tissues, etc.) outside the human body, including reagents, reagent products, calibration materials, control materials, kits, instruments, etc. Devices, equipment or systems, including blood testing, urine testing and so on. This report focuses on in vitro diagnostic reagents and takes into account some consumables to explore the development trend and investment opportunities of this industry.
In vitro diagnostic reagents belong to the biological products industry, which is a subdivision of the diagnostic reagents industry.
In vitro diagnostic reagents are used alone or in combination with instruments, instruments, equipment or systems for in vitro detection of human samples (various body fluids, cells, tissue samples, etc.) in the process of disease prevention, diagnosis, treatment monitoring, prognosis observation, health evaluation and prediction of hereditary diseases. Reagents, kits, calibration products, quality control products and so on. Their working principles are as follows: diagnostic reagents react with substances in vivo biochemically in vitro, and certain substances in body fluids, such as sugar, fat and protein, react with diagnostic reagents in vitro under specific conditions to produce specific products and eliminate them. Quantitative in vitro diagnostic reagents, which can be measured qualitatively or quantitatively, can be compared with normal values to determine whether the physiological state of the subjects is normal.